# Bactolac Pharmaceutical, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/bactolac-pharmaceutical-inc/6448ddc2-938d-490b-960d-d958c552f9bb

> Inspection records and compliance data for Bactolac Pharmaceutical, Inc. in Hauppauge, New York. Access full analysis and detailed observations.

---

## Details

- Name: Bactolac Pharmaceutical, Inc.
- FEI Number: 3000207006
- City: Hauppauge
- State: New York
- Country Name: United States
- Address Line 1: 7 Oser Ave
- Zip Code: 11788

## Related Documents

- [483 - Bactolac Pharmaceutical, Inc. - 2025-09-24](https://www.keypedia.com/records/483/bactolac-pharmaceutical-inc/d58b3e6a-6b5d-4d3f-881d-499771520cb9) — source: FDA, date: September 24, 2025
- [483 - Bactolac Pharmaceutical, Inc. - 2025-09-24](https://www.keypedia.com/records/483/bactolac-pharmaceutical-inc/857c551c-8f15-45a6-a8be-02e8dae66baa) — source: FDA, date: September 24, 2025
- [FDA Inspection 1282686 - Bactolac Pharmaceutical, Inc. - 2025-09-24](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/01623a06-fc6f-4d03-9a12-6fbe35cc8678) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2025
- [FDA Inspection 1282686 - Bactolac Pharmaceutical, Inc. - 2025-09-24](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/e4804e9b-a7ca-4047-9669-3aacc8ee4126) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2025
- [483 - Bactolac Pharmaceutical, Inc. - 2025-02-07](https://www.keypedia.com/records/483/bactolac-pharmaceutical-inc/478af956-5153-4db0-a53c-4b6fa00c1f95) — source: FDA, date: February 7, 2025
- [FDA Inspection 1251763 - Bactolac Pharmaceutical, Inc. - 2025-02-07](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/1736a64d-1cc0-4266-9107-45cd3cca6c2f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1251763 - Bactolac Pharmaceutical, Inc. - 2025-02-07](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/bb313c3b-f7cb-4df1-aa7d-1eae961d6f44) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1251763 - Bactolac Pharmaceutical, Inc. - 2025-02-07](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/6344a861-495d-4227-9c82-4b064fb9db3f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- [483 - Bactolac Pharmaceutical, Inc. - 2021-11-19](https://www.keypedia.com/records/483/bactolac-pharmaceutical-inc/e212490d-5689-479c-bddb-1be40103b899) — source: FDA, date: November 19, 2021
- [FDA Inspection 1157283 - Bactolac Pharmaceutical, Inc. - 2021-11-19](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/e98f8fa3-4740-4d2e-9221-a75c67535d7b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 19, 2021
- [FDA Inspection 1157283 - Bactolac Pharmaceutical, Inc. - 2021-11-19](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/921d5ce8-3e4f-43dd-9bb2-1548e3c6ab21) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 19, 2021
- [FDA Inspection 991912 - Bactolac Pharmaceutical, Inc. - 2016-10-27](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/76b03d28-d2f0-4c99-a793-38ecae9a0a0f) — classification: No Action Indicated (NAI), source: FDA, date: October 27, 2016
- [FDA Inspection 978326 - Bactolac Pharmaceutical, Inc. - 2016-05-24](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/f5d8c4a9-2447-4218-b6b3-9059f7a59b89) — classification: No Action Indicated (NAI), source: FDA, date: May 24, 2016
- [483 - Bactolac Pharmaceutical, Inc. - 2015-06-25](https://www.keypedia.com/records/483/bactolac-pharmaceutical-inc/63b4ee4a-6f2a-48ea-b009-1755b80158bf) — source: FDA, date: June 25, 2015
- [FDA Inspection 930221 - Bactolac Pharmaceutical, Inc. - 2015-06-25](https://www.keypedia.com/records/fda_inspections/bactolac-pharmaceutical-inc/6f2f0dcc-510b-4870-acc8-14e47e138615) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 25, 2015

## Related Companies

- [Terumo Cardiovascular Systems Corporation](https://www.keypedia.com/companies/terumo-cardiovascular-systems-corporation/27d34ede-00fd-45aa-b5e4-6158781b6854)
- [Fagron, Inc](https://www.keypedia.com/companies/fagron-inc/32e6861b-84b5-4daa-a189-8f2470413595)
- [Setton Pistachio of Terra Bella, Inc.](https://www.keypedia.com/companies/setton-pistachio-of-terra-bella-inc/c550441e-26d7-4e4e-a3d8-9d7c4a840869)
- [Automated Ophthalmics, Inc.](https://www.keypedia.com/companies/automated-ophthalmics-inc/3c8cfd75-5794-4841-acac-7e0b25ffe992)
- [IsoTis OrthoBiologics, Inc.](https://www.keypedia.com/companies/isotis-orthobiologics-inc/df4a7da7-92c2-474d-b810-2ad643c54425)
- [American Contract Systems, Inc.](https://www.keypedia.com/companies/american-contract-systems-inc/a472a3ba-5229-4a20-a8bb-0e10b1be11f7)
- [Stason Pharmaceuticals, Inc.](https://www.keypedia.com/companies/stason-pharmaceuticals-inc/f8669d38-d60b-4f0c-856a-ac536c422fae)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928)
- [Generitech Corporation](https://www.keypedia.com/companies/generitech-corporation/25805817-388a-4536-8a14-7e1b75078fba)
- [Tishcon Corp](https://www.keypedia.com/companies/tishcon-corp/a780a8ca-0e6b-41fb-b487-d2729bb0f88f)

## Related Officers

- [Eric J. Reisenauer](https://www.keypedia.com/people/eric-j-reisenauer/28c369cc-bb5c-41f8-a73b-77d85825a10f)
- [Investigator](https://www.keypedia.com/people/meredith-p-soehl/52252b59-8f03-41e4-a86f-b92c98048023)
- [Investigator -Pathologist](https://www.keypedia.com/people/dana-a-razzano/cc0ae25a-1513-465e-a0df-bb4022e2670c)